Phase
Condition
Warts
Molluscum Contagiosum
Human Papilloma Virus (Hpv)
Treatment
Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP)
Clinical Study ID
Ages 4-21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
All patients from 4-21 years old with at least 1 lesion of vercurra or molluscum.
Willingness of the participant and their guardian to provide consent whenapplicable.
Exclusion
Exclusion Criteria:
Unwillingness to participate in the study
Received any treatment on the lesion in the past month determined by review of theirmedical record
Immunodeficiency determined by review of their medical record.
Adverse response to prior treatments determined by review of medical record.
Signs of self-resolution determined by study team members.
Conditions that lead to excessive scarring determined by study team members.
Face and genital lesions determined by study team members.
Study Design
Connect with a study center
Medical University of South Carolina
Charleston, South Carolina 29425
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.